Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Other Working Capital Changes (2021 - 2025)

PAVmed (PAVM) has 5 years of Other Working Capital Changes data on record, last reported at -$345000.0 in Q3 2025.

  • For Q3 2025, Other Working Capital Changes changed N/A year-over-year to -$345000.0; the TTM value through Sep 2025 reached -$339000.0, changed N/A, while the annual FY2024 figure was -$832000.0, 438.21% down from the prior year.
  • Other Working Capital Changes reached -$345000.0 in Q3 2025 per PAVM's latest filing, down from $449000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.5 million in Q4 2021 and bottomed at -$1.5 million in Q4 2023.
  • Average Other Working Capital Changes over 5 years is $143777.8, with a median of $158000.0 recorded in 2023.
  • Peak YoY movement for Other Working Capital Changes: tumbled 331.03% in 2022, then soared 197.35% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at $1.5 million in 2021, then crashed by 162.34% to -$960000.0 in 2022, then tumbled by 57.4% to -$1.5 million in 2023, then soared by 83.26% to -$253000.0 in 2024, then plummeted by 36.36% to -$345000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$345000.0 in Q3 2025, $449000.0 in Q2 2025, and -$190000.0 in Q1 2025.